Susquehanna International Group
TPST icon

Susquehanna International Group’s Tempest Therapeutics TPST Stock Holding History

Susquehanna International Group’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,812
Closed -$62.6K – 13732
2025
Q1 		$84.5K Sell
8,812
-682
-7% -$7.74K ﹤0.01% 11643
2024
Q4 		$103K Buy
9,494
+6,013
+173% +$77.6K ﹤0.01% 11320
2024
Q3 		$63.4K Buy
+3,481
New +$71.3K ﹤0.01% 11288
2024
Q2 		– Sell
-1,781
Closed -$90.6K – 13250
2024
Q1 		$90.6K Sell
1,781
-6,250
-78% -$316K ﹤0.01% 11276
2023
Q4 		$459K Buy
+8,031
New +$380K ﹤0.01% 8882
2023
Q2 		– Sell
-853
Closed -$25.7K – 13151
2023
Q1 		$25.7K Buy
+853
New +$18.7K ﹤0.01% 11970
2021
Q2 		– Sell
-94
Closed -$21.1K – 13268
2021
Q1 		$22K Sell
94
-63
-40% -$25.5K ﹤0.01% 12133
2020
Q4 		$65K Buy
157
+77
+96% +$26.6K ﹤0.01% 10680
2020
Q3 		$25K Sell
80
-39
-33% -$13.2K ﹤0.01% 10358
2020
Q2 		$41K Buy
+119
New +$47.5K ﹤0.01% 9803
2017
Q3 		– Sell
-39
Closed -$176K – 9633
2017
Q2 		$176K Buy
39
+18
+86% +$76.2K ﹤0.01% 8385
2017
Q1 		$113K Sell
21
-10
-32% -$46.6K ﹤0.01% 8337
2016
Q4 		$138K Buy
31
+23
+288% +$287K ﹤0.01% 8902
2016
Q3 		$176K Sell
8
-3
-27% -$54.3K ﹤0.01% 7679
2016
Q2 		$164K Buy
11
+6
+120% +$137K ﹤0.01% 7764
2016
Q1 		$128K Sell
5
-3
-38% -$63.4K ﹤0.01% 8314
2015
Q4 		$233K Sell
8
-4
-33% -$132K ﹤0.01% 8167
2015
Q3 		$289K Sell
12
-25
-68% -$1.68M ﹤0.01% 8096
2015
Q2 		$3.1M Buy
37
+29
+363% +$2.66M ﹤0.01% 3786
2015
Q1 		$828K Buy
+8
New +$1.07M ﹤0.01% 6130
2013
Q3 		– Sell
-5
Closed -$191K – 8777
2013
Q2 		$191K Buy
+5
New +$188K ﹤0.01% 7470

Other funds holding TPST

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group's TPST Position: Q2 2025 in Review

Susquehanna International Group sold out of Tempest Therapeutics (TPST) in Q2 2025, closing a stake of 8,812 shares — an estimated $62.6K sold.

Susquehanna International Group first reported a position in TPST in Q2 2013 and held it in 21 quarters. The position peaked at $3.1M in Q2 2015. 18 funds tracked by Wall St. Rank hold TPST as of Q2 2025.

  • Susquehanna International Group reported no remaining Tempest Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 8,812 Tempest Therapeutics shares in Q2 2025, an estimated $62.6K.
  • Susquehanna International Group first reported a position in Tempest Therapeutics in Q2 2013 and held it in 21 quarters.
  • Susquehanna International Group's Tempest Therapeutics position peaked at $3.1M in Q2 2015.
  • 18 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.